US RE40,023 E1 | ||
Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use | ||
Claudio DeSimone, Via Fabretti, 8, 00161 Roma (Italy) | ||
Filed on Mar. 15, 2006, as Appl. No. 11/375,704. | ||
Application 08/448787 is a continuation of application No. 08/117751, filed on Sep. 08, 1993, abandoned. | ||
Application 08/117751 is a continuation in part of application No. 07/983839, filed on Dec. 01, 1992, abandoned. | ||
Application 11/375704 is a reissue of application No. 08/448787, filed on May 24, 1995, now 5,716,615, filed on Feb. 10, 1998. | ||
Claims priority of application No. MI92A0256 (IT), filed on Feb. 10, 1992. | ||
Int. Cl. A61K 38/44 (2006.01); C12N 1/04 (2006.01); C12N 1/20 (2006.01) |
U.S. Cl. 424—93.4 [424/93.44; 424/93.45; 426/61; 435/252.4; 435/252.9; 435/253.4; 435/260; 435/856; 435/885] | 33 Claims |
1. A pharmaceutical composition comprising:
a) from 10% to 95% by weight of total composition of lyophilized Streptococcus thermophilus, and
b) from 5% to 90% by weight of total composition of at least one lyophilized bacterium selected from the group consisting
of Lactobacillus plantarum and Lactobacillus casei, and
c) from 0% to 10% by weight of total composition a pharmaceutically acceptable excipient,
wherein said Streptococcus thermophilus and the bacterium b) are present in a concentration of 1×1011-1×1013 total bacteria per gram of the composition.
|